DocGo’s (DCGO) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of DocGo (NASDAQ:DCGO) in a report published on Wednesday,Benzinga reports.

DCGO has been the topic of several other research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a research note on Monday, September 14th. Canaccord Genuity Group reissued a “hold” rating and set a $1.00 target price on shares of DocGo in a research note on Tuesday, August 18th. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $2.38.

DocGo Trading Down 6.3%

Shares of NASDAQ DCGO opened at $0.37 on Wednesday. DocGo has a one year low of $0.31 and a one year high of $1.65. The firm has a market capitalization of $36.55 million, a PE ratio of -0.19 and a beta of 0.97. The business has a 50-day moving average price of $0.47 and a two-hundred day moving average price of $0.56.

DocGo (NASDAQ:DCGO) last issued its earnings results on Monday, August 17th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The business had revenue of $73.42 million during the quarter, compared to analyst estimates of $75.35 million. DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. Research analysts anticipate that DocGo will post -0.22 EPS for the current year.

Hedge Funds Weigh In On DocGo

A number of institutional investors have recently modified their holdings of the company. S Squared Technology LLC bought a new stake in shares of DocGo during the 2nd quarter worth $1,060,725. Renaissance Technologies LLC boosted its holdings in DocGo by 167.1% during the first quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after acquiring an additional 944,826 shares during the period. BlackRock Inc. acquired a new stake in shares of DocGo in the second quarter valued at about $750,000. Isthmus Partners LLC increased its stake in shares of DocGo by 14.0% in the first quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock worth $637,000 after purchasing an additional 124,211 shares during the period. Finally, GSA Capital Partners LLP acquired a new position in shares of DocGo during the 2nd quarter worth about $517,000. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.